These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 25170193)

  • 21. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of unidimensional transient elastography in staging chronic hepatitis C. Results from a cohort of 1,202 biopsied patients from one single center.
    Lupsor Platon M; Stefanescu H; Feier D; Maniu A; Badea R
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):157-66. PubMed ID: 23799214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-invasive diagnosis of liver fibrosis in chronic hepatitis C.
    Schiavon Lde L; Narciso-Schiavon JL; de Carvalho-Filho RJ
    World J Gastroenterol; 2014 Mar; 20(11):2854-66. PubMed ID: 24659877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
    Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
    J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
    Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
    World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection.
    El Guesiry D; Moez P; Hossam N; Kassem M
    Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.
    Matta B; Lee TH; Patel K
    Curr HIV/AIDS Rep; 2016 Oct; 13(5):279-88. PubMed ID: 27485838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latent Class Analysis of Noninvasive Methods and Liver Biopsy in Chronic Hepatitis C: An Approach without a Gold Standard.
    Fernandes FF; Perazzo H; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Ferraz ML; Perez RM
    Biomed Res Int; 2017; 2017():8252980. PubMed ID: 29057268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time tissue elastography: non-invasive evaluation of liver fibrosis in chronic liver disease due to HCV.
    Shiraishi A; Hiraoka A; Aibiki T; Okudaira T; Kawamura T; Imai Y; Tatsukawa H; Yamago H; Nakahara H; Shimizu Y; Suga Y; Azemoto N; Tanihira T; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Hiasa Y; Matsuura B; Kawasaki H; Furuya K; Michitaka K
    Hepatogastroenterology; 2014 Oct; 61(135):2084-90. PubMed ID: 25713914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers.
    Agbim U; Asrani SK
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):361-374. PubMed ID: 30791772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.
    Stasi C; Milani S
    World J Gastroenterol; 2016 Jan; 22(4):1711-20. PubMed ID: 26819535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cohort study: Apparent redundancy of fibrosis assessment in young persons with HCV; development of realistic approaches to break the paradigm.
    Paul Noel B; Peter C; Emma R; Asthika A; Francis DJ
    Ann Hepatol; 2022; 27(1):100550. PubMed ID: 34606981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
    Vergniol J; Foucher J; Terrebonne E; Bernard PH; le Bail B; Merrouche W; Couzigou P; de Ledinghen V
    Gastroenterology; 2011 Jun; 140(7):1970-9, 1979.e1-3. PubMed ID: 21376047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.
    Bonnard P; Elsharkawy A; Zalata K; Delarocque-Astagneau E; Biard L; Le Fouler L; Hassan AB; Abdel-Hamid M; El-Daly M; Gamal ME; El Kassas M; Bedossa P; Carrat F; Fontanet A; Esmat G
    J Viral Hepat; 2015 Mar; 22(3):245-53. PubMed ID: 25073725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C.
    Zarski JP; Sturm N; Guechot J; Zafrani ES; Vaubourdolle M; Thoret S; Margier J; David-Tchouda S; Bosson JL
    PLoS One; 2013; 8(3):e59088. PubMed ID: 23555619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced liver disease in Russian children and adolescents with chronic hepatitis C.
    Turkova A; Volynets GV; Crichton S; Skvortsova TA; Panfilova VN; Rogozina NV; Khavkin AI; Tumanova EL; Indolfi G; Thorne C
    J Viral Hepat; 2019 Jul; 26(7):881-892. PubMed ID: 30803105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fibrosis: the 2017 state of art.
    Caviglia GP; Rosso C; Fagoonee S; Saracco GM; Pellicano R
    Panminerva Med; 2017 Dec; 59(4):320-331. PubMed ID: 28880053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.